$12.17
0.060.5%
Last update: Nov 11, 7:15 AM

The average analyst price target for Corteva is $78.53, 542.6% above the current price. Of 15 analysts, 13 rate it Buy and 2 Hold. Targets range from $15 to $103. The latest change came on Oct 12, 2026, when UBS lowered its price target on Corteva from $90 to $15 and kept a Neutral rating.
Price Target Range — 10 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months